12:00 AM
Mar 29, 1999
 |  BC Week In Review  |  Company News  |  Deals

Hemosol Inc., Fresenius AG deal

HML received a C$2.1 million (US$1.4 million) milestone from partner Fresenius for starting a Phase III trial...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >